Featured Network Trials
LCCC1028 Title: Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease Response and Recurrence and to Establish Predictive Biomarkers of Drug Activity in Renal Cell Carcinoma
PI, Kim Rathmell Affiliate Coordinator, Donna Rowe, Telephone: (919) 966-2152 or EMAIL.
LCCC1011 Title: A Phase II Trial of Bendamustine in Combination with Rituximab in Older Patients with Previously Untreated Diffuse Large B-cell Lymphoma
LCCC1029 Title: Multi-Center, Randomized Placebo-Controlled Phase II Study of Regorafenib in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) versus Placebo and FOLFIRI as Second Line Therapy in Patients with Metastatic Colorectal Cancer
LCCC0921: Title A Multi-Center Open Label Phase II Study of Pazopanib In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer After Progression on First Line Therapy Containing Bevacizumab.
PI, Tom Stinchcombe Affiliate Coordinator, Donna Rowe, Telephone: (919) 966-2152 or EMAIL.
LCCC1025 Title: A Phase II Study Evaluating the Efficacy And Tolerability Of Everolimus (RAD001) In Combination With Trastuzumab And Vinorelbine In The Treatment Of Progressive HER2-Positive Breast Cancer Brain Metastases
PI, Carey Anders Affiliate Coordinator, Donna Rowe, Telephone: (919) 966-2152 or EMAIL.